Entering text into the input field will update the search result below

Sutro Biopharma appoints Borgman as Chief Medical Officer

Feb. 28, 2023 9:07 AM ETSutro Biopharma, Inc. (STRO) StockBy: Meghavi Singh, SA News Editor
  • Sutro Biopharma (NASDAQ:STRO) has appointed Anne Borgman, M.D., as Chief Medical Officer, effective February 28, 2023. 
  • Dr. Borgman, most recently served as Vice President and Therapeutic Area Lead, Oncology, Hematology, and Transplant, at Jazz Pharmaceuticals.
  • Dr. Borgman brings over 20 years of oncology and hematology drug development experience to Sutro, including extensive regulatory experience in both the U.S. and Europe, leading to nine regulatory approvals.

Recommended For You

More Trending News

About STRO Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
STRO--
Sutro Biopharma, Inc.